Alkermes seeks U.K, German Vivitrol OK |
|
|
|
Published
:
Mon, 02 Apr 2007 23:43
|
CAMBRIDGE, Mass. (AP) - Biotechnology company Alkermes Inc. said Monday it asked U.K. and German regulators to approve its extended-release Vivitrol to treat alcohol dependence.The submission is under a decentralized process where the U.K. will act as a reference member state and Germany as the concerned member state for the application. If it is approved in one nation, it will receive simultaneous approval in the other.The drug received U.S. Food and Drug Administration approval in April 2006.Shares of Alkermes fell 9 cents to close at $15.35 on the Nasdaq Stock Market.Copyright 2007 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2251.69 |
-12.87 (
-0.56 %)
|
| SYMBOL (
2010-07-29 ) |
| LAST |
CHANGE
|
|
KAZAKHMYS
(
11:37am )
|
|
1220.00 |
+23.00 (
1.91 %)
|
|
LONMIN
(
11:35am )
|
|
1580.00 |
+21.00 (
1.35 %)
|
|
SHIRE
(
11:35am )
|
|
1490.00 |
+21.00 (
1.43 %)
|
| SYMBOL (
2010-07-29 )
|
| LAST |
CHANGE
|
|
DUPONT
(
4:00pm ) |
|
40.51 |
+0.24 (
0.59 %)
|
| SYMBOL (
2010-07-29 )
|
| LAST |
CHANGE
|
|
|
Print this Story
Alkermes 3Q profit doubles 